Comparing Self Monitored Blood Glucose (SMBG) to Continuous Glucose Monitoring (CGM) in Type 2 Diabetes
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 124 participants.
Also called NCT01237301
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 124 participants
- Sponsor
- HealthPartners Institute
- Registry
-
NCT01237301
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01237301. Randomized; no masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2012-03 (actual). Results posted on 2014-01-06.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparing Self Monitored Blood Glucose (SMBG) to Continuous Glucose Monitoring (CGM) in Type 2 Diabetes
- Acronym
- REACT3
- Condition
- Type 2 Diabetes
- Intervention (Device)
- CGM Group
- Intervention (Device)
- SMBG Group
- Lead sponsor
- HealthPartners Institute
- Collaborator
- Roche Diagnostics GmbH
- Collaborator
- International Diabetes Center at Park Nicollet
Record details
- Record id
cardio:ct-nct01237301- Content hash
c6ea1b697b14cf3860bb3b8095f77af5cca2ad298ec4495a1b7cb008efda4bce